Schonfeld Strategic Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
+101,505
| New | +$2.62M | 0.02% | 761 |
|
|
2024
Q2 | – | Sell |
-35,720
| Closed | -$501K | – | 2238 |
|
|
2024
Q1 | $501K | Buy |
35,720
+10,560
| +42% | +$148K | ﹤0.01% | 1303 |
|
|
2023
Q4 | $213K | Buy |
25,160
+17,213
| +217% | +$146K | ﹤0.01% | 1432 |
|
|
2023
Q3 | $71K | Buy |
7,947
+5,814
| +273% | +$51.9K | ﹤0.01% | 1377 |
|
|
2023
Q2 | $18.4K | Buy |
2,133
+473
| +28% | +$4.08K | ﹤0.01% | 1765 |
|
|
2023
Q1 | $17.5K | Sell |
1,660
-6,654
| -80% | -$70.2K | ﹤0.01% | 1770 |
|
|
2022
Q4 | $282K | Sell |
8,314
-5,847
| -41% | -$198K | ﹤0.01% | 1803 |
|
|
2022
Q3 | $680K | Buy |
14,161
+8,948
| +172% | +$430K | 0.01% | 1513 |
|
|
2022
Q2 | $297K | Buy |
+5,213
| New | +$297K | ﹤0.01% | 1597 |
|
|
2022
Q1 | – | Sell |
-2,721
| Closed | -$552K | – | 2597 |
|
|
2021
Q4 | $552K | Sell |
2,721
-4,300
| -61% | -$872K | 0.01% | 1145 |
|
|
2021
Q3 | $1.89M | Buy |
7,021
+3,099
| +79% | +$835K | 0.02% | 672 |
|
|
2021
Q2 | $1.01M | Buy |
3,922
+709
| +22% | +$183K | 0.01% | 889 |
|
|
2021
Q1 | $964K | Buy |
+3,213
| New | +$964K | 0.01% | 874 |
|
|
2020
Q3 | – | Sell |
-3,534
| Closed | -$1.23M | – | 1504 |
|
|
2020
Q2 | $1.23M | Buy |
+3,534
| New | +$1.23M | 0.03% | 517 |
|
|
2019
Q4 | – | Sell |
-3,320
| Closed | -$907K | – | 1390 |
|
|
2019
Q3 | $907K | Buy |
+3,320
| New | +$907K | 0.03% | 493 |
|
|
2018
Q2 | – | Sell |
-1,387
| Closed | -$2.21M | – | 885 |
|
|
2018
Q1 | $2.21M | Buy |
+1,387
| New | +$2.21M | 0.17% | 182 |
|
|
2016
Q4 | – | Sell |
-1,454
| Closed | -$375K | – | 617 |
|
|
2016
Q3 | $375K | Buy |
+1,454
| New | +$375K | 0.06% | 298 |
|